Name: Latest research reports of Laurus Labs Ltd. authored by Keynote Capitals Ltd and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: Keynote Capitals Ltd

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	10 Jul 2025	Laurus Labs	Consensus Share Price Target	792.95	577.69	-	-27.15	hold	pdf Detailed Estimates
	31 Mar 2023	Laurus Labs	Keynote Capitals Ltd	792.95	396.00	292.95 (170.68%)	Target met	Buy	pdf post cache	Broker Report Laurus Labs Limited Keynote Capitals Ltd Initiating Coverage Report pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2023	Laurus Labs	ICICI Direct Target	792.95	400.00	330.30 (140.07%)	Target met	Buy	pdf post cache	Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	30 Jan 2023	Laurus Labs	Motilal Oswal Target	792.95	440.00	341.80 (131.99%)	Target met	Buy	pdf post cache	Broker Report Synthesis/Non-ARV API drives earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	22 Oct 2022	Laurus Labs	ICICI Direct Target	792.95	630.00	486.25 (63.07%)		Buy	pdf post cache	Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	22 Oct 2022	Laurus Labs	BOB Capital Markets Ltd. Reco Target	792.95	540.00	486.25 (63.07%)		Hold	pdf post cache	Broker Report Laurus Labs (HOLD): CDMO scale-up masks otherwise dismal Q2; cut to HOLD BOB Capital Markets Ltd. Q2 revenue grew 31% YoY (+2% QoQ) led by synthesis division and other APIs; FDF revenue at record-low of Rs 1.5bn pdf Copy Link Share on Share on Share on Share on Alert
	28 Jul 2022	Laurus Labs	ICICI Direct Target	792.95	675.00	525.25 (50.97%)		Buy	pdf post cache	Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	28 Jul 2022	Laurus Labs	BOB Capital Markets Ltd. Reco	792.95	645.00	522.70 (51.70%)		Buy	pdf post cache	Broker Report Laurus Labs (BUY): Synthesis business saves the day BOB Capital Markets Ltd. Q1 revenue/EBITDA came in 5%/8% above consensus and grew 20%/ 15% YoY to Rs 15.4bn/Rs 4.5bn pdf Copy Link Share on Share on Share on Share on Alert
	30 Apr 2022	Laurus Labs	ICICI Direct	792.95	690.00	583.35 (35.93%)		Buy	pdf post cache	Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	29 Apr 2022	Laurus Labs	BOB Capital Markets Ltd. Target	792.95	645.00	593.35 (33.64%)		Hold	pdf post cache	Broker Report Laurus Labs (HOLD): Mixed Q4; non-ARV business guided to drive $1bn in sales BOB Capital Markets Ltd. Q4 topline growth 14% ahead of consensus as healthy CDMO, FDF and non-ARV API sales offset decline in ARV business pdf Copy Link Share on Share on Share on Share on Alert
	29 Jan 2022	Laurus Labs	BOB Capital Markets Ltd. Reco Target	792.95	570.00	502.70 (57.74%)	Target met	Hold	pdf post cache	Broker Report Laurus Labs (HOLD): PAT declines 44% on negative operating leverage BOB Capital Markets Ltd. Inventory destocking in ARV API/FDF led to 20% YoY decline in revenue; guided to normalise from Q4 pdf Copy Link Share on Share on Share on Share on Alert
more loading

New 52W High today

Laurus Labs Ltd. share price target

Laurus Labs Ltd. has an average share price target of 649.60. The consensus estimate represents a downside of -18.08% from the last price of 792.95. View 13 reports from 5 analysts offering long-term price targets for Laurus Labs Ltd..

Laurus Labs Limited

Laurus Labs

Synthesis/Non-ARV API drives earnings

Laurus Labs

Laurus Labs (HOLD): CDMO scale-up masks otherwise dismal Q2; cut to HOLD

Laurus Labs

Laurus Labs (BUY): Synthesis business saves the day

Laurus Labs

Laurus Labs (HOLD): Mixed Q4; non-ARV business guided to drive $1bn in sales

Laurus Labs (HOLD): PAT declines 44% on negative operating leverage

Advisor Screeners